Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes

Diabetic Medicine : a Journal of the British Diabetic Association
F S NazirStephen J Cleland

Abstract

Diabetes is a major risk factor for stroke, but the mechanisms that impart the excess risk are unclear. Endothelial dysfunction, which has been demonstrated in the coronary and peripheral vasculature of diabetic patients, is an important early marker of vascular disease. However, the effect of diabetes on cerebrovascular endothelium has not been examined. We sought to investigate the effect of diabetes on basal cerebrovascular endothelial function as assessed by response to the nitric oxide synthase (NOS) inhibitor NG-monomethyl-L-arginine (L-NMMA). Fourteen men with Type 2 diabetes and 15 age-matched male control subjects were recruited. The participants had no clinically evident vascular disease and were taking no vasoactive or lipid-lowering medication. Each received a single 15-min intravenous infusion of L-NMMA (0.8 mol/kg/min). Cerebral blood flow was assessed by colour Doppler imaging of the internal carotid artery (ICA) at 10-min intervals for 20 min prior to and following the infusion. Middle cerebral artery velocity (MCAv) was assessed by transtemporal Doppler ultrasound at the same time points. L-NMMA produced a mean reduction in ICA flow area under curve (AUC) in the control group of 12.8 +/- 17.8% compared with a 2...Continue Reading

References

May 11, 1979·JAMA : the Journal of the American Medical Association·W B Kannel, D L McGee
Jun 1, 1986·British Journal of Pharmacology·H AzumaS Sekizaki
Nov 1, 1995·Journal of the American College of Cardiology·T J AndersonA C Yeung
Jul 1, 1996·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M AldasoroS Lluch
Mar 21, 1998·Journal of the American College of Cardiology·F K TimimiM A Creager
Jan 5, 2000·Journal of Diabetes and Its Complications·B FülesdiL Csiba
Apr 25, 2000·American Journal of Physiology. Heart and Circulatory Physiology·P HeM Zeng
Mar 8, 2003·Stroke; a Journal of Cerebral Circulation·Salah-Eddine MegherbiUNKNOWN European BIOMED Study of Stroke Care Group
Nov 5, 2003·Annals of Neurology·Matthias EndresUlrich Laufs

❮ Previous
Next ❯

Citations

Oct 15, 2011·Cellular and Molecular Life Sciences : CMLS·Akhlaq A FarooquiVincenza Frisardi
Dec 24, 2013·Journal of Cardiothoracic and Vascular Anesthesia·Patrice BrassardJean S Bussières
May 21, 2013·Diabetes Research and Clinical Practice·Vladimira VuleticVida Demarin
May 25, 2010·Cardiovascular Therapeutics·T J QuinnM R Walters
Oct 6, 2016·Clinical and Experimental Pharmacology & Physiology·William K KarlssonChristina Kruuse
Feb 4, 2012·World Journal of Critical Care Medicine·Chien-Wei Hsu
Jun 24, 2011·Surgical Neurology International·Mohammadali M ShojaAaron A Cohen-Gadol
Sep 17, 2016·Clinical Science·Trevor HardiganAdviye Ergul
Dec 14, 2018·Journal of Applied Physiology·Silvana RobertoAntonio Crisafulli
Jan 20, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Lauro C ViannaPaul J Fadel
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Basal Ganglia Cerebrovascular Disease

Basal ganglia cerebrovascular disease is a condition where the blood vessels in the basal ganglia are damaged or malfunction. Discover the latest research on basal ganglia cerebrovascular disease here.